Genentech

TECENTRIQ

  1. Home
  2.  / 
  3. J Code
  4.  / TECENTRIQ – J9022

Manufacturer:

Genentech

Name:

TECENTRIQ

HCPCS Code Descriptor:

Injection, atezolizumab, 10 mg

Category:

J Code

HCPCS:

J9022

NDC(s):

50242-0917-01, 50242-0918-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

TECENTRIQ is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9022 is aligned to the drug TECENTRIQ.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/18

HCPCS Effective Date:

1/1/18

HCPCS Short Description:

Inj, atezolizumab,10 mg

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.gene.com/patients/patient-foundation